BioCryst's Orladeyo reduces HAE attack rate by 80% over a period of 96 weeks
12 July 2021 - 4:51PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
From Apr 2023 to Apr 2024